Privia Health Group’s (PRVA) “Buy” Rating Reiterated at Needham & Company LLC

Privia Health Group (NASDAQ:PRVA)‘s stock had its “buy” rating reissued by stock analysts at Needham & Company LLC in a research note issued to investors on Friday,Benzinga reports. They presently have a $30.00 price target on the stock. Needham & Company LLC’s target price points to a potential upside of 28.53% from the stock’s current price.

PRVA has been the topic of several other reports. Canaccord Genuity Group lifted their price target on Privia Health Group from $29.00 to $30.00 and gave the stock a “buy” rating in a research report on Friday, February 28th. Macquarie assumed coverage on Privia Health Group in a research report on Monday, December 16th. They issued an “outperform” rating and a $25.00 price target on the stock. Stephens reissued an “overweight” rating and set a $26.00 price objective on shares of Privia Health Group in a report on Thursday, January 2nd. JMP Securities set a $29.00 price objective on Privia Health Group in a report on Friday, February 28th. Finally, Piper Sandler lifted their price objective on Privia Health Group from $25.00 to $40.00 and gave the stock an “overweight” rating in a report on Friday, February 28th. One investment analyst has rated the stock with a hold rating, thirteen have given a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat.com, Privia Health Group has an average rating of “Buy” and a consensus target price of $26.67.

Privia Health Group Stock Up 0.2 %

Shares of NASDAQ PRVA opened at $23.34 on Friday. The business’s 50 day moving average is $23.65 and its two-hundred day moving average is $21.03. The company has a market cap of $2.81 billion, a P/E ratio of 233.42, a P/E/G ratio of 3.47 and a beta of 0.85. Privia Health Group has a 12 month low of $15.92 and a 12 month high of $26.04.

Institutional Trading of Privia Health Group

Several institutional investors have recently bought and sold shares of PRVA. Victory Capital Management Inc. boosted its stake in Privia Health Group by 402.9% in the 3rd quarter. Victory Capital Management Inc. now owns 179,049 shares of the company’s stock valued at $3,260,000 after buying an additional 143,446 shares in the last quarter. KBC Group NV boosted its stake in Privia Health Group by 34.6% in the third quarter. KBC Group NV now owns 3,385 shares of the company’s stock worth $62,000 after purchasing an additional 871 shares in the last quarter. Intech Investment Management LLC acquired a new position in Privia Health Group in the third quarter worth $462,000. Charles Schwab Investment Management Inc. boosted its stake in Privia Health Group by 6.5% in the third quarter. Charles Schwab Investment Management Inc. now owns 1,064,224 shares of the company’s stock worth $19,380,000 after purchasing an additional 65,152 shares in the last quarter. Finally, Icon Wealth Advisors LLC boosted its stake in Privia Health Group by 1,910.1% in the third quarter. Icon Wealth Advisors LLC now owns 300,889 shares of the company’s stock worth $5,479,000 after purchasing an additional 285,920 shares in the last quarter. Institutional investors and hedge funds own 94.48% of the company’s stock.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.